aspirin has been researched along with Premature Rupture of Fetal Membranes in 5 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of this study is to determine whether low-dose aspirin (LDA) reduced the rate of preterm birth (PTB) in a cohort of women at high risk for preeclampsia." | 9.22 | The impact of low-dose aspirin on preterm birth: secondary analysis of a randomized controlled trial. ( Allshouse, AA; Heyborne, KD; Jessel, RH, 2016) |
| "The objective of this study is to determine whether low-dose aspirin (LDA) reduced the rate of preterm birth (PTB) in a cohort of women at high risk for preeclampsia." | 5.22 | The impact of low-dose aspirin on preterm birth: secondary analysis of a randomized controlled trial. ( Allshouse, AA; Heyborne, KD; Jessel, RH, 2016) |
| "8 mg per kilogram of body weight per day) and aspirin (100 mg per day) or placebo for the duration of the pregnancy." | 5.08 | Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. ( Bombardier, C; Farewell, V; Farine, D; Fielding, L; Hannah, ME; Laskin, CA; Mandel, FP; Ritchie, JW; Soloninka, CA; Spitzer, K; Yeung, M, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moussa, HN | 1 |
| Wu, ZH | 1 |
| Han, Y | 1 |
| Pacheco, LD | 1 |
| Blackwell, SC | 1 |
| Sibai, BM | 1 |
| Saade, G | 1 |
| Costantine, MM | 1 |
| Allshouse, AA | 1 |
| Jessel, RH | 1 |
| Heyborne, KD | 1 |
| Stone, S | 1 |
| Hunt, BJ | 1 |
| Seed, PT | 1 |
| Parmar, K | 1 |
| Khamashta, MA | 1 |
| Poston, L | 1 |
| Laskin, CA | 1 |
| Bombardier, C | 1 |
| Hannah, ME | 1 |
| Mandel, FP | 1 |
| Ritchie, JW | 1 |
| Farewell, V | 1 |
| Farine, D | 1 |
| Spitzer, K | 1 |
| Fielding, L | 1 |
| Soloninka, CA | 1 |
| Yeung, M | 1 |
| Fuller, WE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Low Dose Prednisone Therapy in Women With Recurrent Pregnancy Loss[NCT04558268] | Phase 2/Phase 3 | 242 participants (Anticipated) | Interventional | 2020-12-31 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for aspirin and Premature Rupture of Fetal Membranes
| Article | Year |
|---|---|
Customized versus Population Fetal Growth Norms and Adverse Outcomes Associated with Small for Gestational Age Infants in a High-Risk Cohort.
Topics: Aspirin; Birth Weight; Cesarean Section; Cyclooxygenase Inhibitors; Female; Fetal Development; Fetal | 2015 |
The impact of low-dose aspirin on preterm birth: secondary analysis of a randomized controlled trial.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dose-Response Relationship, Drug; Female; F | 2016 |
Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss.
Topics: Abortion, Habitual; Adolescent; Adult; Aspirin; Autoantibodies; Female; Fetal Membranes, Premature R | 1997 |
2 other studies available for aspirin and Premature Rupture of Fetal Membranes
| Article | Year |
|---|---|
Longitudinal evaluation of markers of endothelial cell dysfunction and hemostasis in treated antiphospholipid syndrome and in healthy pregnancy.
Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Biomarkers; Dalteparin; Endothelium, Vascular; F | 2003 |
Management of premature labor.
Topics: Aspirin; Bed Rest; Betamethasone; Estrogens; Ethanol; Female; Fetal Membranes, Premature Rupture; Gl | 1978 |